(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three most active and biggest winners today are iFresh, Catalyst Pharmaceuticals, and Nautilus.

Rank Financial Asset Price Change Updated (EST)
1 iFresh (IFMK) 0.03 50% 2022-07-13 14:34:47
2 Catalyst Pharmaceuticals (CPRX) 8.53 10.27% 2022-07-13 14:56:40
3 Nautilus (NLS) 2.05 10.22% 2022-07-13 14:47:51
4 MacroGenics (MGNX) 4.02 9.54% 2022-07-13 11:49:19
5 Twitter (TWTR) 36.76 7.93% 2022-07-13 14:51:25
6 Antero Resources (AR) 32.94 7.44% 2022-07-13 14:56:08
7 iShares FTSE EPRA/NAREIT Europe (IFEU) 35.08 7.21% 2022-07-12 19:08:06
8 Myriad Genetics (MYGN) 20.85 6.95% 2022-07-13 16:23:13
9 Trip.com (TCOM) 26.18 6.49% 2022-07-13 14:50:53
10 Ambev (ABEV) 2.67 6.37% 2022-07-13 14:40:27

The three most active and biggest losers today are TherapeuticsMD, Marrone Bio Innovations, and Masimo Corporation.

Rank Financial Asset Price Change Updated (EST)
1 TherapeuticsMD (TXMD) 5.19 -37.24% 2022-07-13 14:51:11
2 Marrone Bio Innovations (MBII) 0.80 -20.19% 2022-07-13 09:15:06
3 Masimo Corporation (MASI) 122.69 -6.66% 2022-07-13 09:10:06
4 Fastenal Company (FAST) 46.83 -6.32% 2022-07-13 14:57:37
5 SemiLEDS Corporation (LEDS) 2.58 -6.18% 2022-07-13 05:07:19
6 Zoom (ZM) 101.41 -6.09% 2022-07-13 14:51:50
7 Sabre Corporation (SABR) 5.97 -6.05% 2022-07-13 14:59:24
8 Lantronix (LTRX) 4.91 -5.03% 2022-07-13 07:46:15
9 Old Dominion Freight Line (ODFL) 249.87 -4.92% 2022-07-13 14:58:44
10 Niu Technologies (NIU) 6.40 -4.9% 2022-07-13 14:49:59

Most Active Winners today

1. iFresh (IFMK) – 50%

Through its subsidiaries, iFresh Inc. operates a network grocery store chains in the northern-eastern United States. The company operates in two segments: Wholesale and Retail. It offers vegetables, seafood and meats as well as snacks and seasonings. The company’s brands include Feiyan and Green Acre as well as Redolent, Redolent, Redolent, Redolent, Redolent and I FRESH. It also sells products in wholesale shops, supermarkets and restaurants. It had nine supermarkets, two wholesale shops and one in-house business. It sells its products online and has a delivery network throughout suburban areas. Founded in 1995, iFresh Inc. is based in Long Island City (New York).

NASDAQ ended the session with iFresh rising 50% to $0.03 on Wednesday while NASDAQ slid 0.15% to $11,247.58.

Volume

Today’s last reported volume for iFresh is 15621 which is 1969.01% above its average volume of 755.

iFresh’s last close was $0.02, 98.81% under its 52-week high of $1.68.

iFresh’s Revenue

Year-on-year quarterly revenue growth grew by 22.7%, now sitting on 94.26M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

iFresh’s stock is considered to be oversold (<=20).

iFresh’s Stock Yearly Top and Bottom Value

iFresh’s stock is valued at $0.03 at 17:32 EST, way below its 52-week high of $1.68 and way higher than its 52-week low of $0.00.

iFresh’s Moving Average

iFresh’s value is way above its 50-day moving average of $0.01 and way below its 200-day moving average of $0.28.

More news about iFresh.

2. Catalyst Pharmaceuticals (CPRX) – 10.27%

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical firm that focuses on the development and commercialization of therapies for individuals with neurological and rare neuromuscular diseases. Firdapse is a unique form of amifampridinephosphate that can be used to treat patients suffering from lambert-eaton syndrome. Firdapse is also being developed by the company. It has been in clinical trials to treat patients suffering from congenital myasthenic disorder, anti-MuSK antibody negative myasthenia Gravis and spinal muscular atrophy. Catalyst Pharmaceuticals, Inc. is a licensee of BioMarin Pharmaceutical Inc. and has a collaboration agreement and license agreement for Endo Ventures Limited to develop and market generic Sabril tablets. Catalyst Pharmaceutical Partners, Inc. was the company’s former name. In May 2015, Catalyst Pharmaceuticals, Inc. changed its name. Catalyst Pharmaceuticals, Inc., was established in 2002. It is located in Coral Gables, Florida.

NASDAQ ended the session with Catalyst Pharmaceuticals jumping 10.27% to $8.53 on Wednesday while NASDAQ slid 0.15% to $11,247.58.

Volume

Today’s last reported volume for Catalyst Pharmaceuticals is 2111600 which is 75% above its average volume of 1206590.

Catalyst Pharmaceuticals’s last close was $7.74, 10.52% below its 52-week high of $8.65.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 56.2% for the ongoing quarter and 54.1% for the next. The company’s growth estimates for the present quarter and the next is 54.5% and 90%, respectively.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 23.5%, now sitting on 140.83M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Catalyst Pharmaceuticals’s stock is considered to be oversold (<=20).

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $8.53 at 17:32 EST, under its 52-week high of $8.65 and way above its 52-week low of $4.81.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s value is way higher than its 50-day moving average of $7.03 and way above its 200-day moving average of $6.93.

More news about Catalyst Pharmaceuticals.

3. Nautilus (NLS) – 10.22%

NYSE ended the session with Nautilus rising 10.22% to $2.05 on Wednesday while NYSE fell 0.38% to $14,340.29.

Volume

Today’s last reported volume for Nautilus is 540202 which is 42.41% below its average volume of 938138.

Nautilus’s last close was $1.86, 88.84% below its 52-week high of $16.67.

Nautilus’s Sales

Nautilus’s sales growth is a negative 41% for the ongoing quarter and a decline by 31.7% for the next. The company’s growth estimates for the current quarter and the next is a negative 161.7% and a negative 172.1%, respectively.

Nautilus’s Revenue

Year-on-year quarterly revenue growth declined by 22.2%, now sitting on 664.91M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Nautilus’s stock is considered to be overbought (>=80).

Nautilus’s Stock Yearly Top and Bottom Value

Nautilus’s stock is valued at $2.05 at 17:32 EST, way below its 52-week high of $16.67 and way above its 52-week low of $1.70.

Nautilus’s Moving Average

Nautilus’s worth is way under its 50-day moving average of $2.46 and way under its 200-day moving average of $5.61.

More news about Nautilus.

4. MacroGenics (MGNX) – 9.54%

MacroGenics, Inc., is a biopharmaceutical firm that develops anti-cancer therapies. The approved product of the company is MARGENZA, margetuximab cmkb, which is a human epidermal Growth Factor 2 (HER2) antagonist. It’s indicated in combination chemotherapy for adult patients with metastatic HER2-positive Breast Cancer who have had at least two prior anti-HER2 treatments. Margetuximab is a monoclonal anti-HER2 antibody that the company has in its Phase II/III clinical trials for treatment of gastroesophageal and breast cancers. The company is also developing Flotetuzumab, a DART molecule that recognizes CD123 and CD3 for treating acute myeloid leukemia; Retifanlimab, an investigational monoclonal antibody targeting metastatic squamous cell carcinoma of the anal canal and metastatic non-small cell lung cancer; Enoblituzumab, a monoclonal antibody that targets B7-H3; and Tebotelimab, an investigational tetravalent DART molecule for PD-1 and lymphocyte-activation gene 3. In addition, it is developing MGC018, an antibody drug conjugate (ADC), which targets solid tumors expressing B7-H3; MGD019, a monoclonal antibody that targets the immune checkpoints PD-1 and cytotoxic T-lymphocyte-associated protein 4; and IMGC936, an ADC that targets ADAM9, a cell surface protein over-expressed in various solid tumor types. MGD014, which is a DART-molecule that targets the envelope protein in human immunodeficiency viruses-infected cells, and T cells, and Teplizumab, for treatment of type 1, are among the non-immuno oncology product candidates. PRV-3279 is a CD32B-A–CD79B DART-molecule for treatment of autoimmune indications. There are collaborations with Incyte Corporation, Zai Lab Limited, Janssen Biotech, Inc., and Alligator Bioscience AB. Rockville, Maryland is the headquarters of the company.

NASDAQ ended the session with MacroGenics jumping 9.54% to $4.02 on Wednesday while NASDAQ slid 0.15% to $11,247.58.

Volume

Today’s last reported volume for MacroGenics is 669156 which is 47.53% below its average volume of 1275350.

MacroGenics’s last close was $3.67, 86.93% under its 52-week high of $28.09.

The company’s growth estimates for the present quarter is a negative 45.5% and positive 36% for the next.

MacroGenics’s Revenue

Year-on-year quarterly revenue growth declined by 73.2%, now sitting on 77.45M for the twelve trailing months.

MacroGenics’s Stock Yearly Top and Bottom Value

MacroGenics’s stock is valued at $4.02 at 17:32 EST, way below its 52-week high of $28.09 and way above its 52-week low of $2.13.

MacroGenics’s Moving Average

MacroGenics’s worth is higher than its 50-day moving average of $3.77 and way under its 200-day moving average of $11.71.

More news about MacroGenics.

5. Twitter (TWTR) – 7.93%

Twitter, Inc. is a social media platform that allows people to express themselves and have conversations in real-time, both nationally and internationally. It offers a variety of products and services. These include Twitter, which allows users to create, consume, and distribute content. Periscope is a mobile app that allows you to live broadcast with other people. The company also offers promoted services and products such as promoted Twitters, promoted accounts and promoted trends. This allows advertisers to market their products and services. The company also offers tools and public APIs to developers that allow them to add their content to the platform and syndicate it across other properties. Developers can then enhance their websites and apps with Twitter content. It also offers subscription access to the public data feed of data partners. Twitter, Inc. was established in 2006 in San Francisco, California.

NYSE ended the session with Twitter jumping 7.93% to $36.76 on Wednesday while NYSE slid 0.38% to $14,340.29.

Volume

Today’s last reported volume for Twitter is 46020100 which is 19.96% above its average volume of 38361400.

Twitter’s last close was $34.06, 53.56% below its 52-week high of $73.34.

The company’s growth estimates for the current quarter is a negative 25% and positive 138.9% for the next.

Twitter’s Revenue

Year-on-year quarterly revenue growth grew by 15.9%, now sitting on 5.24B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Twitter’s stock is considered to be overbought (>=80).

Twitter’s Stock Yearly Top and Bottom Value

Twitter’s stock is valued at $36.76 at 17:32 EST, way under its 52-week high of $73.34 and way higher than its 52-week low of $31.30.

Twitter’s Moving Average

Twitter’s value is way under its 50-day moving average of $41.78 and way under its 200-day moving average of $44.92.

Previous days news about Twitter

  • Twitter stock falls as Elon Musk abandons takeover, but Tesla charges on. According to FXStreet on Monday, 11 July, "Musk is terminating the Merger Agreement because Twitter is in material breach of multiple provisions of that Agreement, appears to have made false and misleading representations upon which Mr.", "We believe fair value now $30 with bear case $25 for Twitter as the Street adjusts to a new normal for the stock with Musk terminating the deal. "
  • Twitter reports 36% increase in gaming tweets in first half of 2022. According to VentureBeat on Tuesday, 12 July, "Roughly 1.5 billion tweets about gaming were made on Twitter in the first half of 2022. "
  • Twitter sues Elon Musk for attempting to back out of $44 billion deal. According to MarketWatch on Tuesday, 12 July, "This repudiation follows a long list of material contractual breaches by Musk that have cast a pall over Twitter and its business.", "In its suit, Twitter said it repeatedly cooperated with Musk to complete the deal "in accordance with the terms of the merger agreement" that includes providing Musk access to raw data on tweets being sent daily."

More news about Twitter.

6. Antero Resources (AR) – 7.44%

Antero Resources Corporation is an independent oil-and-natural gas company that acquires, investigates, develops and produces natural gaz, natural gas liquids and other oil properties throughout the United States. The company owned approximately 451,000 acres of net land in the Marcellus Shale’s southwestern core and 91,000 acres of net land in the Utica Shale core as of December 31, 2019. The company also operated 324 mile of Marcellus Shale gas gathering pipelines, 17 compressor stations and 110 miles of Utica Shale low-pressure/high-pressure gathering pipelines. It also owns and operates 8 miles high-pressure pipelines and two compressor stations. It had proved natural gas reserves estimated at 18.9 trillion cubic yards, which included 11.5 trillion cubic meters of natural gas, 652 million barrels assumed-recovered ethane and 540 million barrels each of normal butane and propane; as well as 42 million barrels oil. Antero Resources Appalachian Corporation was the company’s former name. In June 2013, it changed its name from Antero Resources Corporation to Antero Resources Corporation. Antero Resources Corporation was established in 2002. It is located in Denver, Colorado.

NYSE ended the session with Antero Resources jumping 7.44% to $32.94 on Wednesday, following the last session’s downward trend. NYSE slid 0.38% to $14,340.29, after three consecutive sessions in a row of losses, on what was a somewhat negative trend exchanging session today.

Volume

Today’s last reported volume for Antero Resources is 7591150 which is 18.51% below its average volume of 9315640.

Antero Resources’s last close was $30.66, 37.17% below its 52-week high of $48.80.

The company’s growth estimates for the current quarter and the next is 1007.7% and 689.5%, respectively.

Antero Resources’s Revenue

Year-on-year quarterly revenue growth grew by 30.5%, now sitting on 6.93B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Antero Resources’s stock is considered to be overbought (>=80).

Antero Resources’s Stock Yearly Top and Bottom Value

Antero Resources’s stock is valued at $32.94 at 17:32 EST, way below its 52-week high of $48.80 and way higher than its 52-week low of $10.91.

Antero Resources’s Moving Average

Antero Resources’s value is way below its 50-day moving average of $37.09 and way higher than its 200-day moving average of $25.76.

More news about Antero Resources.

7. iShares FTSE EPRA/NAREIT Europe (IFEU) – 7.21%

NASDAQ ended the session with iShares FTSE EPRA/NAREIT Europe rising 7.21% to $35.08 on Wednesday, after five sequential sessions in a row of losses. NASDAQ slid 0.15% to $11,247.58, after two consecutive sessions in a row of losses, on what was a somewhat down trend trading session today.

More news about iShares FTSE EPRA/NAREIT Europe.

8. Myriad Genetics (MYGN) – 6.95%

Myriad Genetics, Inc., an American molecular diagnostics company, creates and sells personalized, predictive, and prognostic medicine test in the United States as well as internationally. MyRisk Hereditary Cancer is a genetic sequencing test that can detect hereditary breast cancers. BRACAnalysis is a test that determines the likelihood of developing ovarian and breast cancer. RiskScore provides personalized medicine tools. There is also BRACAnalysis CDx which can be used to identify ovarian or HER2 positive metastatic breast cancers. GeneSight allows for the selection of psychotropic drugs for depression patients. Vectra is a test that quantifies protein levels and helps in evaluating the disease activity associated with rheumatoid. Foresight is a prenatal testing tool that allows future parents to determine their chances of having a child with a recessive condition. Prequel can also be used to perform a screening for serious chromosomal conditions in the fetus. Prolaris is a test that measures the severity of prostate cancer. EndoPredict is a test that determines the aggressiveness and risk of breast cancer. MyPath Melanoma can be used to diagnose melanoma. myChoice CDx provides a companion diagnostic. It measures three types of homologous mutation deficiency: loss of heterozygosity and telomeric allele imbalance. The company also offers services in biomarker discovery and pharmaceutical and clinical support to the medical, pharmaceutical and biotechnology industries. It operates an emergency room for internal medicine, hemodialysis, and internal medicine. Illumina, Inc. has been a strategic partner. Myriad Genetics, Inc., was established in 1991. It is located in Salt Lake City, Utah.

NASDAQ ended the session with Myriad Genetics rising 6.95% to $20.85 on Wednesday while NASDAQ fell 0.15% to $11,247.58.

Volume

Today’s last reported volume for Myriad Genetics is 537404 which is 1.49% below its average volume of 545581.

Myriad Genetics’s last close was $19.50, 47.23% under its 52-week high of $36.95.

The company’s growth estimates for the current quarter is a negative 91.7% and positive 50% for the next.

Myriad Genetics’s Revenue

Year-on-year quarterly revenue growth grew by 4%, now sitting on 690.6M for the twelve trailing months.

Myriad Genetics’s Stock Yearly Top and Bottom Value

Myriad Genetics’s stock is valued at $20.85 at 17:32 EST, way under its 52-week high of $36.95 and way higher than its 52-week low of $16.02.

Myriad Genetics’s Moving Average

Myriad Genetics’s value is above its 50-day moving average of $19.61 and way under its 200-day moving average of $25.12.

More news about Myriad Genetics.

9. Trip.com (TCOM) – 6.49%

Trip.com Group Limited is a Chinese travel agency that offers accommodation booking, travel ticketing, in-destination packages, corporate travel management and other services. It acts as an agent in hotel-related transactions as well as selling tickets for air flights. The company also offers other services such as sale of airline and train insurances, delivery services and online check-in. Independent leisure travelers can also purchase packaged tour products that include group tours and semi-group tours. They also offer customized tours and packages with different transportation options, including flights, cars, boats, and cruises. The company also offers integrated transport and accommodation services. It provides a variety of value-added service, including transportation to destinations, tickets, activities and visa services. Tour guides are available. Customer, supplier and relationship management services are offered. It also provides corporate clients with data and industry benchmarks, cost-saving analysis and travel management solutions. The company’s Corporate Travel Management System is an online platform which integrates information maintenance and online booking, authorization, enquiry and travel reporting. The company also offers financial and online advertising services. The company operates under the Skyscanner, Qunar and Ctrip brands. Ctrip.com International, Ltd. was the company’s previous name. In October 2019, Trip.com Group Limited became Trip.com Group Limited. Trip.com Group Limited, which was established in 1999, is located in Shanghai (People’s Republic of China).

NASDAQ ended the session with Trip.com rising 6.49% to $26.18 on Wednesday, after two successive sessions in a row of gains. NASDAQ fell 0.15% to $11,247.58, after two sequential sessions in a row of losses, on what was a somewhat negative trend trading session today.

Volume

Today’s last reported volume for Trip.com is 5421520 which is 9.02% below its average volume of 5959380.

Trip.com’s last close was $24.59, 41.51% under its 52-week high of $42.04.

Trip.com’s Revenue

Year-on-year quarterly revenue growth declined by 2.2%, now sitting on 20.31B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Trip.com’s stock is considered to be overbought (>=80).

Trip.com’s Stock Yearly Top and Bottom Value

Trip.com’s stock is valued at $26.18 at 17:32 EST, way under its 52-week high of $42.04 and way above its 52-week low of $14.29.

Trip.com’s Moving Average

Trip.com’s value is way above its 50-day moving average of $23.51 and below its 200-day moving average of $26.68.

More news about Trip.com.

10. Ambev (ABEV) – 6.37%

Through its subsidiaries, Ambev S.A. produces, distributes and sells beer and draft beer as well as carbonated soft drinks (CSD) and other non-alcoholic beverages. The company operates in three areas: Brazil, Central America and South America; Latin America South; Canada. The beer is sold under three brands: Skol, Brahma and Antarctica; Brahva Gold, Extra and Budweiser. CSD, bottled and isotonic drinks, energy drinks and coconut water are also available. Ambev S.A. sells its products via a network distributors as well as a direct distribution channel. It was established in 1885. The company is located in SAPSo Paulo in Brazil. Ambev S.A., a subsidiary Interbrew International B.V.

NYSE ended the session with Ambev rising 6.37% to $2.67 on Wednesday, after two successive sessions in a row of losses. NYSE fell 0.38% to $14,340.29, after three sequential sessions in a row of losses, on what was a somewhat negative trend trading session today.

Volume

Today’s last reported volume for Ambev is 46253000 which is 44.49% above its average volume of 32010100.

Ambev’s last close was $2.51, 29.3% under its 52-week high of $3.55.

The company’s growth estimates for the present quarter and the next is a negative 25% and a negative 25%, respectively.

Ambev’s Revenue

Year-on-year quarterly revenue growth grew by 18.6%, now sitting on 72.85B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Ambev’s stock is considered to be overbought (>=80).

Ambev’s Stock Yearly Top and Bottom Value

Ambev’s stock is valued at $2.67 at 17:32 EST, way below its 52-week high of $3.55 and way higher than its 52-week low of $2.42.

Ambev’s Moving Average

Ambev’s worth is below its 50-day moving average of $2.76 and below its 200-day moving average of $2.84.

More news about Ambev.

Most Active Losers Today

1. TherapeuticsMD (TXMD) – -37.24%

TherapeuticsMD, Inc. is a United States women’s health company. The company provides IMVEXXY, a treatment for moderate-to severe dyspareunia, and BIJUVA which is a bioidentical hormonal therapy combination of 17AY-estradiol, progesterone, for moderate to severe vasomotor symptoms. TX-015HR is a transdermal patch candidate that contains progesterone and estradiol. TX-009HR is the company’s clinical product. It contains an oral progesterone/estradiol formula. The company also produces and distributes generic and branded prescription prenatal vitamins under the vitaTrue and vitaMedMD brands. It sells prescription hormone therapy drugs and prenatal vitamins to both wholesale and retail pharmacie distributors. TherapeuticsMD, Inc., is located in Boca Raton, Florida.

NASDAQ ended the session with TherapeuticsMD dropping 37.24% to $5.19 on Wednesday, after two successive sessions in a row of gains. NASDAQ dropped 0.15% to $11,247.58, after two successive sessions in a row of losses, on what was a somewhat negative trend trading session today.

Volume

Today’s last reported volume for TherapeuticsMD is 3662780 which is 179.49% above its average volume of 1310520.

TherapeuticsMD’s last close was $8.27, 200.73% above its 52-week high of $2.75.

TherapeuticsMD’s Sales

TherapeuticsMD’s sales growth is 33.7% for the ongoing quarter and 29.3% for the next. The company’s growth estimates for the current quarter and the next is 16.7% and 40%, respectively.

TherapeuticsMD’s Revenue

Year-on-year quarterly revenue growth grew by 114.9%, now sitting on 84.79M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

TherapeuticsMD’s stock is considered to be overbought (>=80).

TherapeuticsMD’s Stock Yearly Top and Bottom Value

TherapeuticsMD’s stock is valued at $5.19 at 17:32 EST, way above its 52-week high of $2.75.

TherapeuticsMD’s Moving Average

TherapeuticsMD’s value is way above its 50-day moving average of $0.66 and way higher than its 200-day moving average of $1.00.

More news about TherapeuticsMD.

2. Marrone Bio Innovations (MBII) – -20.19%

Marrone Bio Innovations, Inc. develops, manufactures, promotes, and markets biological products to manage pests, nutrition, and health of plants in the United States as well as internationally. Foramin ST and Pacesetter are some of its products. Grandevo is a bioinsecticide to stop sucking insects by feeding them; Jet-Oxide and Jet-Ag peroxyacetic acids sanitizers to prevent sunburn and reduce plant stress; Majestene is a bionematicide that can be used to combat soil-dwelling and soil-borne insects. Regalia, Stargus and Stargus are biofungicides which protect against fungal or bacterial diseases, enhance yields/quality, and control chewing, sucking, and mites through feeding. Zelto is a bionematicide which protects and improves the health of turf by increasing plant and root health. It sells its products through direct sales, distributors, and other commercial partners. Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. is the former name of this company. It was founded in 2006 in Davis, California.

NASDAQ ended the session with Marrone Bio Innovations dropping 20.19% to $0.80 on Wednesday, after two successive sessions in a row of losses. NASDAQ dropped 0.15% to $11,247.58, after two successive sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.

Volume

Today’s last reported volume for Marrone Bio Innovations is 7393700 which is 702.84% above its average volume of 920938.

Marrone Bio Innovations’s last close was $0.80, 46.79% below its 52-week high of $1.50.

Marrone Bio Innovations’s Sales

Marrone Bio Innovations’s sales growth is 27% for the ongoing quarter and 43.9% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 100% and a negative 33.3%, respectively.

Marrone Bio Innovations’s Revenue

Year-on-year quarterly revenue growth grew by 0.5%, now sitting on 44.37M for the twelve trailing months.

Marrone Bio Innovations’s Stock Yearly Top and Bottom Value

Marrone Bio Innovations’s stock is valued at $0.80 at 17:32 EST, way under its 52-week high of $1.50 and way higher than its 52-week low of $0.55.

Marrone Bio Innovations’s Moving Average

Marrone Bio Innovations’s worth is way below its 50-day moving average of $1.07 and below its 200-day moving average of $0.88.

More news about Marrone Bio Innovations.

3. Masimo Corporation (MASI) – -6.66%

Masimo Corporation designs, produces, and sells noninvasive monitoring technology and solutions for hospital automation worldwide. Masimo Signal Extract Technology (SET) pulseoximetry is offered by the company. It offers measure-through motion pulse oximetry and low pulse oximetry monitoring. This addresses some of the limitations inherent in conventional pulse oximetry. Masimo Rainbow SET Platform also offers noninvasive monitoring of hemoglobin, such as oxygen saturation, pulse rate and perfusion index. It calculates the oxygen reserve index and oxygen content. SedLine brain function technology is offered by the company. It measures brain activity using EEG signals. Capnography products include gas monitors and external gas analyzers. Integrated modules and handheld capsnometers and capnometers. There are also capnography sampling lines. O3 regional oxygenmetry can be used to determine tissue oxygen saturation. Masimo Hospital Automation Platform includes Patient SafetyNet and surveillance; Kite, UniView Replica, UniView 60, MyView; and hemodynamic monitoring solutions. It offers connectivity devices, coronavirus-2019 responses and telehealth solutions. The company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, physician offices, long term care facilities, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was founded in Irvine, California in 1989.

NASDAQ ended the session with Masimo Corporation sliding 6.66% to $122.69 on Wednesday while NASDAQ dropped 0.15% to $11,247.58.

Volume

Today’s last reported volume for Masimo Corporation is 140420 which is 83.76% below its average volume of 864955.

Masimo Corporation’s last close was $131.45, 56.93% under its 52-week high of $305.21.

Masimo Corporation’s Sales

Masimo Corporation’s sales growth is 77.2% for the present quarter and 79.9% for the next. The company’s growth estimates for the ongoing quarter and the next is 27.7% and 20.2%, respectively.

Masimo Corporation’s Revenue

Year-on-year quarterly revenue growth grew by 1.7%, now sitting on 1.24B for the twelve trailing months.

Masimo Corporation’s Stock Yearly Top and Bottom Value

Masimo Corporation’s stock is valued at $122.69 at 17:32 EST, way below its 52-week high of $305.21 and higher than its 52-week low of $112.07.

Masimo Corporation’s Moving Average

Masimo Corporation’s value is below its 50-day moving average of $133.44 and way below its 200-day moving average of $203.73.

More news about Masimo Corporation.

4. Fastenal Company (FAST) – -6.32%

Fastenal Company and its subsidiaries are involved in wholesale distribution of industrial supplies throughout North America. Fastenal is a brand that offers industrial and construction products as well as fasteners. Its fastener product range includes threaded fasteners and bolts, nuts and screws as well as studs and studs. These are used for both manufacturing and construction as well as the repair and maintenance of machinery. Miscellaneous hardware and supplies are also offered by the company, which includes pins and machinery keys, concrete anchors and metal framing system, wire ropes and strut products as well as rivets and other accessories. It serves three markets: original equipment producers; maintenance, repairs, and operations; as well as the non-residential market for construction, which covers general, electric, plumbing and sheet metal contractors. The company also provides services to farmers, trucks, railways, mining firms, schools and retail trades. It is also available for federal, state and local government entities. It distributes its products via a network of 2,114 branches as well as 15 distribution centers. Fastenal Company was established in 1967 in Winona (Minnesota).

NASDAQ ended the session with Fastenal Company falling 6.32% to $46.83 on Wednesday, after three successive sessions in a row of losses. NASDAQ dropped 0.15% to $11,247.58, after two successive sessions in a row of losses, on what was a somewhat negative trend exchanging session today.

Volume

Today’s last reported volume for Fastenal Company is 7609370 which is 128.13% above its average volume of 3335440.

Fastenal Company’s last close was $49.99, 22.8% under its 52-week high of $64.75.

The company’s growth estimates for the ongoing quarter and the next is 19% and 16.7%, respectively.

Fastenal Company’s Revenue

Year-on-year quarterly revenue growth grew by 20.3%, now sitting on 6.3B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Fastenal Company’s stock is considered to be overbought (>=80).

Fastenal Company’s Stock Yearly Top and Bottom Value

Fastenal Company’s stock is valued at $46.83 at 17:32 EST, below its 52-week low of $48.10.

Fastenal Company’s Moving Average

Fastenal Company’s value is way under its 50-day moving average of $52.21 and way under its 200-day moving average of $56.02.

More news about Fastenal Company.

5. SemiLEDS Corporation (LEDS) – -6.18%

SemiLEDs Corporation designs, produces, and markets light emitting diode chips and components. It also sells LED modules and systems internationally. It also offers enhanced vertical LED products in white, green and ultraviolet; LED chips for packagers and distributors; as well as lighting products that are primarily designed to be used by original designers of lighting products. The company packages its LED chips and distributes them to end-users. The company’s products can be used in general lighting applications such as commercial, industrial and residential lighting. It also sells LED chips to packagers or distributors. SemiLEDs Corporation was established in 2005 in Chunan (Taiwan).

NASDAQ ended the session with SemiLEDS Corporation dropping 6.18% to $2.58 on Wednesday while NASDAQ dropped 0.15% to $11,247.58.

Volume

Today’s last reported volume for SemiLEDS Corporation is 81362 which is 17.36% below its average volume of 98461.

SemiLEDS Corporation’s last close was $2.58, 79.62% under its 52-week high of $12.66.

SemiLEDS Corporation’s Stock Yearly Top and Bottom Value

SemiLEDS Corporation’s stock is valued at $2.58 at 17:33 EST, way under its 52-week high of $12.66 and way higher than its 52-week low of $2.05.

SemiLEDS Corporation’s Moving Average

SemiLEDS Corporation’s value is under its 50-day moving average of $2.64 and way under its 200-day moving average of $4.44.

More news about SemiLEDS Corporation.

6. Zoom (ZM) – -6.09%

Zoom Video Communications, Inc. offers a video-first communication platform throughout the Americas, Asia Pacific, Europe, Middle East, Africa. Zoom Meetings is a video-first communications platform that allows for HD video, voice and chat to be shared via mobile devices, computers, phones, tablets, and telephones. Zoom Phone provides call routing and call quality monitoring. Zoom Chat allows customers to share messages, photos, audio files and text on their desktops as well as laptops and tablet devices. Zoom Rooms is a software-based conference system. Zoom Conference Room Connector allows users to connect to SIP/H.3233 endpoints and join Zoom meetings. Zoom Video Webinars lets you host large-scale, online events such as workshops and town hall meetings. The company also offers Zoom for Developers, which allows developers to embed its video, phone and chat into other apps. It also manages Zoom accounts. Zoom App Marketplace allows developers to post their apps. The company serves individuals and businesses in education/media, entertainment/media and finance. Zoom Video Communications, Inc. is a partner with ServiceNow. In May 2012, the company, formerly called Zoom Communications, Inc., changed its name and became Zoom Video Communications, Inc. Zoom Video Communications, Inc. is located in San Jose, California.

NASDAQ ended the session with Zoom falling 6.09% to $101.41 on Wednesday while NASDAQ fell 0.15% to $11,247.58.

Volume

Today’s last reported volume for Zoom is 6740870 which is 24.39% above its average volume of 5418800.

Zoom’s last close was $107.99, 76.1% under its 52-week high of $451.77.

The company’s growth estimates for the current quarter is 10.1% and a drop 13.9% for the next.

Zoom’s Revenue

Year-on-year quarterly revenue growth grew by 35.2%, now sitting on 3.91B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Zoom’s stock is considered to be overbought (>=80).

Zoom’s Stock Yearly Top and Bottom Value

Zoom’s stock is valued at $101.41 at 17:33 EST, way below its 52-week low of $175.27.

Zoom’s Moving Average

Zoom’s worth is way under its 50-day moving average of $246.95 and way under its 200-day moving average of $312.18.

More news about Zoom.

7. Sabre Corporation (SABR) – -6.05%

Sabre Corporation provides technology solutions for the global travel and tourism sector through Sabre Holdings Corporation. The company operates three main segments, namely, Travel Network, Airline Solutions and Hospitality Solutions. As a marketplace for business to-business travel, the Travel Network segment offers information such as prices and inventory from various suppliers. This includes airlines, hotels and car rental brands as well as cruise lines and tour operators. It also has a network that connects with travel buyers, which can include travel management companies and travel agencies. The Airline Solutions segment provides a portfolio of software technology products and solutions through software-as-a-service (SaaS) and hosted delivery models to airlines and other travel suppliers. SabreSonic Customer Sales & Service is a reservation software that allows for the management of sales and customer service at all touchpoints. Sabre AirVision Marketing & Planning provides a suite of commercial planning solutions to airlines. Sabre AirCentre Enterprise Operations offers solutions for managing airline and airport operations. Hospitality Solutions provides solutions and software to hoteliers via SaaS or hosted delivery models. The company offers SynXis central reservation system, SynXis property manager solution for property management, as well as marketing, professional and revenue management services. It was established in Southlake Texas in 2006.

NASDAQ ended the session with Sabre Corporation dropping 6.05% to $5.97 on Wednesday while NASDAQ slid 0.15% to $11,247.58.

Volume

Today’s last reported volume for Sabre Corporation is 6506390 which is 30.51% below its average volume of 9363200.

Sabre Corporation’s last close was $6.36, 51.6% below its 52-week high of $13.14.

Sabre Corporation’s Sales

Sabre Corporation’s sales growth is 61.7% for the ongoing quarter and 54.9% for the next. The company’s growth estimates for the current quarter and the next is 36.5% and 46%, respectively.

Sabre Corporation’s Revenue

Year-on-year quarterly revenue growth grew by 59.6%, now sitting on 1.69B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Sabre Corporation’s stock is considered to be overbought (>=80).

Sabre Corporation’s Stock Yearly Top and Bottom Value

Sabre Corporation’s stock is valued at $5.97 at 17:33 EST, way under its 52-week high of $13.14 and above its 52-week low of $5.52.

Sabre Corporation’s Moving Average

Sabre Corporation’s worth is way under its 50-day moving average of $8.13 and way under its 200-day moving average of $9.49.

More news about Sabre Corporation.

8. Lantronix (LTRX) – -5.03%

Lantronix, Inc. offers software-as-a-service (SaaS), engineering and hardware services for edge computing, remote environment management, IoT, and IoT in Asia Pacific Japan, Europe, Africa, Middle East, Africa, Asia Pacific Japan, and Europe. IoT Connectivity is the company’s IoT product. It provides secure wired and wireless connectivity that increases the utility and value of modern electronic system and equipment. IoT Compute includes application processing that delivers compute to satisfy customer requirements for data transformation and machine learning. IoT Telematics offers power-efficient products that support communication across industrial protocols and interfaces for vehicle, fleet and asset tracking. The company also provides single-board computer and system on modules, development kits, and mechanical, hardware and software engineering services for audio and camera. The company also offers REM products, including out-of-band and console management, power management and IP-connected keyboard-video mouse products. These products provide remote access and control to the IT and networking infrastructure that is deployed at test labs and data centers as well as branch offices and remote sites. Customers can deploy, monitor and manage their global deployments using a single login to the SaaS platform. It sells its products via value-added resellers, system integrators and distributors. The online retailer and original equipment manufacturer can also be used. Lantronix, Inc., was established in Irvine, California in 1989.

NASDAQ ended the session with Lantronix falling 5.03% to $4.91 on Wednesday while NASDAQ fell 0.15% to $11,247.58.

Volume

Today’s last reported volume for Lantronix is 49340 which is 66.95% below its average volume of 149290.

Lantronix’s last close was $4.91, 52.1% below its 52-week high of $10.25.

Lantronix’s Sales

Lantronix’s sales growth is 63.1% for the ongoing quarter and 37.8% for the next. The company’s growth estimates for the present quarter and the next is 33.3% and 25%, respectively.

Lantronix’s Revenue

Year-on-year quarterly revenue growth grew by 103.1%, now sitting on 99.13M for the twelve trailing months.

Lantronix’s Stock Yearly Top and Bottom Value

Lantronix’s stock is valued at $4.91 at 17:33 EST, way below its 52-week high of $10.25 and higher than its 52-week low of $4.55.

Lantronix’s Moving Average

Lantronix’s value is below its 50-day moving average of $5.44 and way under its 200-day moving average of $6.75.

More news about Lantronix.

9. Old Dominion Freight Line (ODFL) – -4.92%

Old Dominion Freight Line, Inc. is a motor carrier that transports less than a truckload in North America and the United States. The company offers LTL services in all regions, as well as inter-regional and national, along with expedited transport. It also provides value-added services such as truckload brokerage and container drayage. It owned 9 288 tractors as of December 31, 2020 and operated 42 service centers, 244 repair shops, and 42 maintenance centres. Old Dominion Freight Line, Inc., was established in 1934. It is located in Thomasville, North Carolina.

NASDAQ ended the session with Old Dominion Freight Line falling 4.92% to $249.87 on Wednesday, after three consecutive sessions in a row of losses. NASDAQ dropped 0.15% to $11,247.58, after two successive sessions in a row of losses, on what was a somewhat negative trend trading session today.

Volume

Today’s last reported volume for Old Dominion Freight Line is 892764 which is 9.74% below its average volume of 989191.

Old Dominion Freight Line’s last close was $262.81, 29.65% below its 52-week high of $373.58.

The company’s growth estimates for the ongoing quarter and the next is 34.6% and 23.9%, respectively.

Old Dominion Freight Line’s Revenue

Year-on-year quarterly revenue growth grew by 32.9%, now sitting on 5.63B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Old Dominion Freight Line’s stock is considered to be overbought (>=80).

Old Dominion Freight Line’s Stock Yearly Top and Bottom Value

Old Dominion Freight Line’s stock is valued at $249.87 at 17:33 EST, way under its 52-week high of $373.58 and higher than its 52-week low of $231.31.

Old Dominion Freight Line’s Moving Average

Old Dominion Freight Line’s value is below its 50-day moving average of $260.14 and way below its 200-day moving average of $302.73.

More news about Old Dominion Freight Line.

10. Niu Technologies (NIU) – -4.9%

Niu Technologies manufactures and sells electric scooters in China. Under the NIU name, Niu Technologies offers e-scooters in NQi (MQi), UQi and Gova series; RQi and Tuqi series urban commuter motorbikes; NIU Aero series professional mountain bikes and road bikes. The company also offers accessories for scooters such as raincoats. gloves. knee pads. storage baskets. tail boxes. smart phone holders. backrests. locks. Lifestyle accessories include T-shirts. coats. jeans. bags. jewelry. notebook. badges. key chains. mugs. Performance upgrade components consist of shock absorbers. brake calipers. and carbon fiber body panels. The company also offers an app called NIU that allows you to request repairs online, locate a service station, report theft, and provide smart services. NIU Cover, which offers insurance, is available as well. NIU Care offers maintenance and reserve services in off-line service stations. It sells its products and services them through franchised shops, city partners, third-party online platforms, as well as the company’s own website. It had 235 partners in cities and 1050 franchised shops in around 180 cities of the People’s Republic of China. There were also 29 international distributors. It was established in Beijing, China in 2014.

NASDAQ ended the session with Niu Technologies falling 4.9% to $6.40 on Wednesday, after four consecutive sessions in a row of losses. NASDAQ slid 0.15% to $11,247.58, after two consecutive sessions in a row of losses, on what was a somewhat down trend trading session today.

Volume

Today’s last reported volume for Niu Technologies is 628035 which is 28.54% above its average volume of 488580.

Niu Technologies’s last close was $6.73, 80.46% below its 52-week high of $34.44.

Niu Technologies’s Revenue

Year-on-year quarterly revenue growth grew by 46.7%, now sitting on 3.7B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Niu Technologies’s stock is considered to be overbought (>=80).

Niu Technologies’s Stock Yearly Top and Bottom Value

Niu Technologies’s stock is valued at $6.40 at 17:33 EST, below its 52-week low of $6.67.

Niu Technologies’s Moving Average

Niu Technologies’s value is way under its 50-day moving average of $8.19 and way below its 200-day moving average of $15.44.

More news about Niu Technologies.

Stay up to date with our winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here